ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Bausch plus Lomb Corporation

Bausch plus Lomb Corporation (BLCO)

16,23
-0,50
(-2,99%)
Geschlossen 11 Juli 10:00PM
16,25
0,02
(0,12%)
Nach Börsenschluss: 1:59AM

Bausch plus Lomb Corporation (BLCO) Aktie

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Wichtige Statistiken und Details

Current Price
16,23
( -2,99% )
Gebot
-
Fragen
-
Volumen
256.994
Durchschnittliches Volumen (3 Mio.)
US$ 444.687
Finanzvolumen
US$ 4.175.529
15,98 Tagesbereich 16,77
13,09 52-Wochen-Bereich 18,915
Marktkapitalisierung
Unternehmenswert
10,993B
Handelsende
16,73
Handelsbeginn
16,68
Letzte Trade
27292
@
16.23
Letzter Handelszeitpunkt
VWAP
16,2476
Erlöse (LTM)
5,21B
Nettogewinn (LTM)
-219M
Ausgegebene Aktien
356.536.358
Streubesitz (%)
12,58%
Institutioneller Besitz (%)
10,39%
Dividendenrendite (LTM)
Kurs-Gewinn-Verhältnis
-27,61
Kurs-Umsatz-Verhältnis (KUV)
1,17
Gewinn pro Aktie (EPS)
-0,62
Beta
0,56

Über Bausch plus Lomb Corporation

Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision C... Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lenses that are indicated for therapeutic use and provide optical correction during healing. It also offers contact lens care products, eye vitamins, mineral supplements, and over-the-counter eye drops that address various conditions, such as eye allergies, conjunctivitis, dry eye, and redness relief. The Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of glaucoma, eye inflammation, ocular hypertension, dry eyes, and retinal diseases. The Surgical segment provides medical device equipment, consumables, and technologies for the treatment of cataracts, corneal, vitreous, and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices for cataract surgery. The company sells its products and services through direct sales forces and independent distributors. Bausch + Lomb Corporation was founded in 1853 and is headquartered in Vaughan, Canada. Bausch + Lomb Corporation operates as a subsidiary of Bausch Health Companies Inc. Mehr anzeigen

Sektor
-
Branche
-
Website
Hauptsitz
Vaughan, Canada
Gegründet
2026
Bausch plus Lomb Corporation is listed in the sector of the New York Börse with ticker BLCO. The last closing price for Bausch plus Lomb was US$16,73. Over the last year, Bausch plus Lomb shares have traded in a share price range of US$ 13,09 to US$ 18,915.

Bausch plus Lomb currently has 356.536.358 shares in issue. The market capitalisation of Bausch plus Lomb is US$5,79 billion. Bausch plus Lomb has a price to earnings ratio (PE ratio) of -27.61.

BLCO Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.95-5.5296856810217.1817.4616.2533009016.90462697CS
40.835.3896103896115.417.4614.6538402315.93521939CS
12-0.71-4.1912632821716.9417.4614.6546287515.84075573CS
26-0.93-5.4195804195817.1618.91514.6542955016.40373387CS
522.1915.598290598314.0418.91513.0949250615.60059919CS
156-3.64-18.319073980919.8721.6910.4556054515.83533205CS
260-2.27-12.270270270318.521.9510.4560246916.03028862CS

BLCO - Frequently Asked Questions (FAQ)

What is the current Bausch plus Lomb Corporation share price?
The current share price of Bausch plus Lomb Corporation is US$ 16,23
How many Bausch plus Lomb Corporation shares are in issue?
Bausch plus Lomb Corporation has 356.536.358 shares in issue
What is the market cap of Bausch plus Lomb Corporation?
The market capitalisation of Bausch plus Lomb Corporation is USD 5,79B
What is the 1 year trading range for Bausch plus Lomb Corporation share price?
Bausch plus Lomb Corporation has traded in the range of US$ 13,09 to US$ 18,915 during the past year
What is the PE ratio of Bausch plus Lomb Corporation?
The price to earnings ratio of Bausch plus Lomb Corporation is -27,61
What is the cash to sales ratio of Bausch plus Lomb Corporation?
The cash to sales ratio of Bausch plus Lomb Corporation is 1,17
What is the registered address of Bausch plus Lomb Corporation?
The registered address for Bausch plus Lomb Corporation is 520 Applewood Crescent, Vaughan, Ontario, L4K 4B4
What is the Bausch plus Lomb Corporation website address?
The website address for Bausch plus Lomb Corporation is www.bausch.com

BLCO Trades

Mehr

Trades verzögert

Um Echtzeit-Trades zu erhalten, aktualisieren Sie Ihr Konto

Auf Echtzeit aktualisieren
Keine Diskussionen Gefunden.
Neuen Thread Erstellen